4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow senicapoc: new trials by email Literature Review of senicapoc trials Research Report on senicapoc
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Senicapoc and Dehydrated Stomatocytosis Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide) - Dehydrated Hereditary Stomatocytosis | Phase 1 / Phase 2 | Completed | Boston Children's Hospital | 5 | 2021-04-15 | 2024-02-22 |
| Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma senicapoc, Placebo - Exercise Induced Asthma | Phase 2 | Completed | Icagen | 69 | 2009-03-01 | 2011-07-14 |
| Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects senicapoc, Placebo - Atopic Asthma | Phase 2 | Completed | Icagen | 34 | 2008-10-01 | 2011-07-14 |
| A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. Low Dose ICA-17043, High dose ICA-17043, Placebo - Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Completed | Icagen | 90 | 2002-02-01 | 2011-07-18 |
Inflammation (2) · Anemia (1) · Anemia, Sickle Cell (1) · Asthma (1) · Asthma, Exercise-Induced (1) · Bronchial Spasm (1) · Xerocytosis, hereditary (1)
Icagen (3) · Boston Children's Hospital (1)
United States (3) · United Kingdom (1)
Carlo Brugnara, MD (1) · Jonathon Stocker, Ph.D. (1) · Kenneth I Ataga, MD (1) · Tak H Lee, FRCP (1)